Urist Marshall Insider Trades & Stock Holdings

EVP, Research & Investments · Royalty Pharma plc · Latest filing Oct 5, 2026

Urist Marshall, EVP, Research & Investments at Royalty Pharma plc has 2 Form 4 trades on file since Sep 28, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($474.41K), net -$474.41K. Latest filing: disposed of 4.13K shares of $RPRX on Oct 5, 2026 at $57.10.

Trades on file

2

Open-market bought

$0

Open-market sold

$474.41K

Net open-market

-$474.41K

Latest filing

Oct 5, 2026

All insider trades by Urist Marshall

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 5, 2026	$RPRX	Sell (Open-market sale) 10b5-1	4.13K	$57.10	$235.59K			+2.0%			EVP, Research & Investments		—
Sep 28, 2026	$RPRX	Sell (Open-market sale) 10b5-1	4.13K	$57.88	$238.81K			-2.9%			EVP, Research & Investments		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Urist Marshall traded

• $RPRX

Frequently asked questions

Has Urist Marshall been buying or selling stock?

Urist Marshall has 0 open-market purchases and 2 open-market sales on file, net -$474.41K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Urist Marshall's latest insider trade?

disposed of 4.13K shares of $RPRX on Oct 5, 2026 at $57.10.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.